We are live on ! Find out more
CPRC

Consolidated Portfolio Review Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 13.59%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+13.59%
3 Year Est. Return
+65.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$723M
AUM Growth
+$98.6M
Cap. Flow
+$55M
Cap. Flow %
7.61%
Top 10 Hldgs %
24.76%
Holding
461
New
83
Increased
229
Reduced
118
Closed
16

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.92M
2
GSUS icon
Goldman Sachs MarketBeta US Equity ETF
GSUS
+$1.84M
3
RWL icon
Invesco S&P 500 Revenue ETF
RWL
+$1.78M
4
PTY icon
PIMCO Corporate & Income Opportunity Fund
PTY
+$1.76M
5
BKT icon
BlackRock Income Trust
BKT
+$1.73M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$2.3M
2
SPOT icon
Spotify
SPOT
+$2.01M
3
SDHY
PGIM Short Duration High Yield Opportunities Fund
SDHY
+$1.88M
4
JRI icon
Nuveen Real Asset Income & Growth Fund
JRI
+$1.37M
5
PDI icon
PIMCO Dynamic Income Fund
PDI
+$1.28M

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 3.06%
3 Healthcare 2.9%
4 Communication Services 2.4%
5 Real Estate 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBB icon
326
iShares MBS ETF
MBB
$39B
$338K 0.05%
+3,602
New +$334K
FEBW icon
327
AllianzIM U.S. Equity Buffer20 Feb ETF
FEBW
$199M
$338K 0.05%
10,573
+2,280
+27% +$70K
VRT icon
328
Vertiv
VRT
$111B
$338K 0.05%
+2,630
New +$256K
BSX icon
329
Boston Scientific
BSX
$74.5B
$337K 0.05%
+3,136
New +$317K
IVOG icon
330
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
$334K 0.05%
2,956
-35
-1% -$3.72K
AZN icon
331
AstraZeneca
AZN
$246B
$331K 0.05%
2,367
– –
TMO icon
332
Thermo Fisher Scientific
TMO
$223B
$328K 0.05%
809
+126
+18% +$52.7K
XIMR icon
333
FT Vest US Equity Buffer & Premium Income ETF March
XIMR
$29.8M
$328K 0.05%
+10,504
New +$323K
ISRG icon
334
Intuitive Surgical
ISRG
$142B
$328K 0.05%
603
+183
+44% +$95.7K
XMAR icon
335
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$155M
$324K 0.04%
+8,464
New +$313K
BKLN icon
336
Invesco Senior Loan ETF
BKLN
$6.75B
$324K 0.04%
15,493
-969
-6% -$20.1K
VTIP icon
337
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
$323K 0.04%
+6,431
New +$321K
EFG icon
338
iShares MSCI EAFE Growth ETF
EFG
$17.4B
$323K 0.04%
+2,881
New +$304K
SOXX icon
339
iShares Semiconductor ETF
SOXX
$46.2B
$322K 0.04%
+1,348
New +$270K
AJG icon
340
Arthur J. Gallagher & Co
AJG
$65.5B
$320K 0.04%
+999
New +$329K
QSPT icon
341
FT Vest Nasdaq-100 Buffer ETF September
QSPT
$643M
$319K 0.04%
10,776
– –
NVS icon
342
Novartis
NVS
$290B
$318K 0.04%
2,629
+31
+1% +$3.49K
PM icon
343
Philip Morris
PM
$290B
$318K 0.04%
1,746
-474
-21% -$81.4K
GDV icon
344
Gabelli Dividend & Income Trust
GDV
$2.68B
$318K 0.04%
12,225
-15,885
-57% -$383K
SFM icon
345
Sprouts Farmers Market
SFM
$8.03B
$317K 0.04%
+1,924
New +$314K
HDV
346
iShares Core High Dividend ETF
HDV
$15B
$312K 0.04%
13,310
+925
+7% +$21.3K
BA icon
347
Boeing
BA
$183B
$311K 0.04%
1,482
+31
+2% +$5.86K
MU icon
348
Micron Technology
MU
$1.03T
$307K 0.04%
2,493
-818
-25% -$76.4K
BLW icon
349
BlackRock Limited Duration Income Trust
BLW
$500M
$306K 0.04%
21,590
-6,381
-23% -$88.2K
RCL icon
350
Royal Caribbean
RCL
$82.4B
$306K 0.04%
+976
New +$232K
12 13
14
15 16

Similar funds

AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
SCM
Sone Capital Management New York $1.19B AUM 14% 1-Year Est. Return
MMFA
Main Management Fund Advisors San Francisco, California $1.19B AUM 26.23% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CCS
Concentric Capital Strategies Stamford, Connecticut $1.19B AUM 44.7% 1-Year Est. Return

Consolidated Portfolio Review Corp's Q2 2025 Portfolio in Review

As of Q2 2025, Consolidated Portfolio Review Corp held 461 positions worth $723M, up 16% from $624M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Consolidated Portfolio Review Corp deployed $55M of net new capital in Q2 2025, opening 83 new positions and adding to 229 existing holdings. Its largest new stake was Goldman Sachs MarketBeta US Equity ETF: 23,309 shares worth $1.99M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Netflix, an estimated $2.3M trimmed.

  • Consolidated Portfolio Review Corp's largest Q2 2025 buy was Goldman Sachs MarketBeta US Equity ETF: 23,309 shares worth $1.99M.
  • Consolidated Portfolio Review Corp added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $2.92M increase.
  • Consolidated Portfolio Review Corp's biggest Q2 2025 reduction was Netflix, cutting an estimated $2.3M.
  • Consolidated Portfolio Review Corp fully exited Spotify in Q2 2025, selling an estimated $2.01M.
  • Consolidated Portfolio Review Corp's ten largest holdings make up 25% of its $723M portfolio in Q2 2025.
  • Consolidated Portfolio Review Corp opened 83 new positions and closed 16 in Q2 2025.
  • Consolidated Portfolio Review Corp's portfolio value rose 16% quarter-over-quarter to $723M.

Based on Consolidated Portfolio Review Corp's 13F filing for Q2 2025, filed 18 Jul 2025.